Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate
The efficient targeting of drugs to tumor cell and subsequent rapid drug release remain primary challenges in the development of nanomedicines for cancer therapy. Here, we constructed a glucose transporter 1 (GLUT1)-targeting and tumor cell microenvironment-sensitive drug release Glucose-PEG-PAMAM-s...
Saved in:
Main Authors: | Pengkai Ma (Author), Yi Sun (Author), Jianhua Chen (Author), Hongpin Li (Author), Hongyu Zhu (Author), Xing Gao (Author), Xinning Bi (Author), Yujie Zhang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLUT1 targeting and hypoxia-activating polymer-drug conjugate-based micelle for tumor chemo-thermal therapy
by: Pengkai Ma, et al.
Published: (2021) -
Hepatocyte-targeting and tumor microenvironment-responsive liposomes for enhanced anti-hepatocarcinoma efficacy
by: Dongliang Cheng, et al.
Published: (2022) -
Twenty Years of Research on Cyclodextrin Conjugates with PAMAM Dendrimers
by: Hidetoshi Arima
Published: (2021) -
Nanoparticles from Gantrez-based conjugates for the oral delivery of camptothecin
by: Judit Huarte, et al.
Published: (2021) -
Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan-Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy
by: Chen Fu, et al.
Published: (2022)